Eisler Capital (US)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,363	Closed	-$2.12M	–	305
2024 Q2	$2.12M	Buy	+15,363	New	+$2.12M	0.04%	90